BJOG An International Journal of Obstetrics & Gynaecology · 2000 · 28 citations · 3 references
Life SciencesGeneticsMolecular GeneticsCancer GeneticsMedical GeneticsMolecular OncologyCervical CancerCervical LesionsGenetic Risk AssessmentGermline Cancer PredispositionGermline Cancer SusceptibilityMalignant NeoplasmsCervical Cancer Risk AssessmentControl Group DesignHuman Papillomavirus StatusHuman Papillomavirus-associated NeoplasiaMatched Control Group
The p53 codon 72 genotype was examined in blood samples taken from 121 Zulu-speaking black South African women with histologically proven squamous carcinoma of the cervix. Freshly biopsied tumour tissue was also available for human papillomavirus subtyping from 100 of these women. A control group consisted of 251 healthy race-matched women attending a contraceptive service facility. The results show that there were no statistically significant differences in the frequency of the homozygous arginine genotype between patients with cancer of cervix, irrespective of human papillomavirus status, and healthy controls. This finding suggests that the arginine allele does not predispose towards viral tumour genesis in this population, and supports the findings of research done in other ethnic groups.
3
Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer
Alan Storey, Miranda Thomas, Ann Kalita et al. · Nature · 1998 · 983 citations
Is p53 Polymorphism Maintained by Natural Selection?
G. Beckman, Richard Birgander, A. Sj auml lander et al. · Human Heredity · 1994 · 362 citations